🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Beautiful study by Teresa Zimmers OHSU Knight Cancer Institute and colleagues

My two NIH cancer research grants were terminated today. One involving breast cancer prevention is an “outstanding investigator award” and had received a perfect score by reviewers. How does ending lifesaving cancer research make Americans healthier? Harvard Medical School @aacr

Delighted to hear from the 17th Dr. Kimryn Rathmell Kimryn Rathmell OHSU Knight Cancer Institute Basic and Translational Sciences Seminar Series about metabolic pathways in RCC #endcancer

Notice of Short-Term Extension to Early-Stage Investigator (ESI) Eligibility Period grants.nih.gov/grants/guide/n…

Congratulations to Somya Khare on being awarded the 2025 Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award by ASH!

"We are working on a promising new therapeutic approach to reduce neuropathy - a debilitating, persistent symptom of chemo. Currently, there are no non-pharmacologic treatment options for patients." - Kerri Winters-Stone on a study published in Journal of Clinical Oncology: bit.ly/3H1l9rK

A new study by Barajas Lab and team used data from 261 patients to build an AI-based model to predict survival from #Glioblastoma and compared brain scans from before and after surgery. They saw the best outcome came from aggressive surgery (via National Cancer Institute): bit.ly/3YZYh29

#Impactful collaborative #Science OHSU News OHSU Radiology Thank you to the NIH National Cancer Institute Jay Bhattacharya, MD, PhD for funding this clinically important research. pubs.rsna.org/doi/10.1148/ra…

🧬 New hope for #PancreaticCancer patients! Teresa Zimmers and team published a study in Journal of Clinical Oncology exploring how to better treat cancer while protecting muscle health. This study is a step toward targeting #Cachexia and improving life during treatment: bit.ly/3YR0PPY

The AACR Outstanding Investigator Award for Breast Cancer Research recognizes an investigator whose work has had or may have a major impact on the etiology, detection, diagnosis, treatment, or prevention of breast cancer. Nominate a colleague by June 30: brnw.ch/21wSTU9

AACR Trailblazer Cancer Research Grants for Early-Stage Investigators provide $1 million over three years to support paradigm-shifting research. Projects may be exploratory, developmental, or proof of concept. Apply by June 12. Learn more: brnw.ch/21wSU1v

A new way to treat chemotherapy-induced peripheral neuropathy 🏥 Researchers Kerri Winters-Stone and Eric Roeland published a study in Journal of Clinical Oncology on the use of low-intensity vibration to reduce symptoms and improve functioning in cancer survivors with CIPN: bit.ly/3H1l9rK

“For patients and families facing a diagnosis of IDH-wildtype #Glioblastoma, our findings provide new hope. We have strong evidence that more extensive tumor removal can translate to meaningful survival gains.” - Barajas Lab on new #GBM study (National Cancer Institute): bit.ly/3YZYh29

Delighted to contribute to this Delphi effort along with OHSU Knight Cancer Institute and 🌎 colleagues Hagen Kennecke Erik Mittra, MD, PhD Adnan Alseidi Neuroendocrine Cancer Foundation NANETS Healing NET 🦓 link.springer.com/article/10.100…

Eagerly awaiting completion of our Vista Pavilion to better serve pts in Oregon & help #endcancer Check out the progress and contribute here: ohsufoundation.org/inpatient-addi…

The AACR Award for Outstanding Achievement in Basic Cancer Research recognizes an early career investigator on the basis of their meritorious achievements in basic cancer research. Nominate a colleague by June 30: brnw.ch/21wSUSE

.Curtis Lachowiez collaborated on research with CU Cancer Center that identified gene mutations and cell maturity as key factors in #AML drug resistance. The study, published in AACR, analyzed data from 678 #AML patients: bit.ly/3SsMHZE

“For patients and families facing a diagnosis of IDH-wildtype #Glioblastoma, our findings provide new hope. We have strong evidence that more extensive tumor removal can translate to meaningful survival gains.” - Barajas Lab on new #GBM study (National Cancer Institute): bit.ly/3YZYh29

See you in #PDX 🌹#RipCity #endcancer 💚 OHSU Knight Cancer Institute OHSU News

The FY26 HHS Budget in Brief has been released. It outlines how the existing NIH institutes & centers will be combined into eight (with only NCI, NIA & NIAID retaining their original structure). There are 40% cuts proposed in NIH budget (including the NCI). 😢 Cancer Research 📉